EXTX: Exact Therapeutics awarded NOK 16 million from Norwegian Research Council for collaboration project with NTNU, ICR and TGen
2022-12-22 08:45:00
OSLO, 22 December 2022: EXACT Therapeutics AS ("EXACT-Tx" or "the Company",
Euronext Growth: EXTX) today announces that the Norwegian Research Council (NRC)
has awarded EXACT-Tx NOK 16 million to support the research of immunotherapy
responses in solid tumours with Acoustic Cluster Therapy (ACT®). The research
project is in collaboration with three renowned academic partners